Belingheri Mirco, Ghio Luciana, Sala Ambra, Menni Francesca, Trespidi Laura, Ferraresso Mariano, Berardinelli Luisa, Rossi Giorgio, Edefonti Alberto, Parini Rossella
Pediatric Nephrology Unit, Maggiore Policlinico Hospital, Mangiagalli and Regina Elena Foundation, IRCCS, Milan, Italy.
Liver Transpl. 2007 May;13(5):762-4. doi: 10.1002/lt.21147.
Glycogen storage disease type Ia (GSD Ia) is a rare metabolic disorder due to hepatic glucose-6-phosphatase deficiency. Although great progress has been made in managing affected patients, severe hypoglycemia, lactic acidosis, hyperlipidemia, hepatic cytolysis, and impaired kidney function are frequent. Liver transplantation is the only radical treatment, for which the main indications are hepatic adenomatosis, hepatocellular carcinoma, or severe hepatic dysfunction. We present the case of a patient with end-stage renal disease without focal hepatic lesions and with moderate hepatic metabolic control, and we explain how combined liver-kidney transplantation (LKT) made it possible to correct the metabolic defects responsible for the impaired glucose homeostasis, liberalize the diet, and give birth to a healthy child after an uneventful pregnancy. Patients with end-stage renal disease that resulted from GSD Ia should be considered for LKT even in the absence of hepatic lesions with the aim of improving their quality of life.
糖原贮积病 Ia 型(GSD Ia)是一种由于肝葡萄糖 -6-磷酸酶缺乏引起的罕见代谢紊乱疾病。尽管在治疗受影响患者方面已取得巨大进展,但严重低血糖、乳酸性酸中毒、高脂血症、肝细胞溶解和肾功能受损仍很常见。肝移植是唯一的根治性治疗方法,其主要适应证为肝腺瘤病、肝细胞癌或严重肝功能障碍。我们报告了一例终末期肾病患者,该患者无局灶性肝脏病变且肝脏代谢控制适度,我们解释了肝肾联合移植(LKT)如何能够纠正导致葡萄糖稳态受损的代谢缺陷,放宽饮食限制,并在顺利妊娠后产下一名健康婴儿。即使没有肝脏病变,对于因 GSD Ia 导致终末期肾病的患者,也应考虑进行 LKT,以改善其生活质量。